Cargill Earns #1 Global Ranking for Removing Trans Fats From Edible Oils Portfolio
International nutrition foundation recognizes Cargill’s global leadership on industrially produced trans-fatty acid removal
Cargill earned the top spot on the inaugural Edible Oil Supplier Index 2025, published by global nonprofit Access to Nutrition initiative (ATNi). The ranking recognizes the company’s leadership in removing industrially produced trans-fatty acids* (iTFAs) from its entire edible oils portfolio, even in markets with no regulatory mandate.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250528074187/en/

Cargill earned the top spot on the inaugural Edible Oil Supplier Index 2025, published by global nonprofit Access to Nutrition initiative (ATNi)
Cargill’s leadership in this space has made a tangible difference for customers and consumers around the world. Chantilly, a cherished brand in Mexico known for its bakery, pastry and confectionery products, is a standout example. The company credits Cargill as a key ally in helping remove iTFAs from its popular whipping cream recipes.
“Cargill provided the expertise and technology needed to solve crucial challenges such as maintaining the taste and texture our consumers and operators expect, while preserving the functionality suitable for various culinary applications,” said Miriam Leticia Rodriguez Chigora, R&D leader, Chantilly. “It not only highlights Cargill's ability to provide technical support and innovative solutions but also its commitment to consumer health and regulatory compliance.”
These efforts are part of what ATNi evaluated in its first-ever ranking of the eight largest edible oil suppliers. The international nutrition organization assessed the companies on 19 indicators across four categories. Cargill earned the highest overall score, 81.4%, leading across all assessment areas, with the second-highest scoring company achieving just 14.2%.
This recognition builds on a major milestone reached in January 2024, when Cargill became the first — and still only known — global edible oil supplier whose entire portfolio complies with the World Health Organization’s (WHO) recommended limit of no more than two grams of iTFAs per 100 grams of fats and oils in food products — a threshold set to protect public health.
Cargill’s journey began years earlier, well ahead of the WHO’s 2018 REPLACE initiative, which called for the global elimination of industrial trans fats. The company invested millions in capital upgrades, committed thousands of R&D hours and helped hundreds of customers reformulate products. To date, Cargill has helped remove more than 1.5 billion pounds of products containing iTFAs from the global food chain.
“Being recognized by ATNi reinforces our responsibility to lead with purpose — delivering safe, sustainable nutrition through the food and ingredient solutions we provide,” said David VandenEinde, Vice President of R&D for Food North America, Cargill. “This achievement is the result of decades of innovation, close collaboration with customers like Chantilly, and investment in improved edible oil solutions. We will remain fully engaged with food manufacturers and related stakeholders, working together to help pave the way for a healthier and more resilient global food supply.”
According to the WHO’s 2024 progress report, as of the end of 2023, only 53 of the world’s 195 countries — covering just 46% of the global population — had adopted one of WHO’s best practice policies to limit iTFA in foods. That reality puts added meaning to ATNi’s call for other suppliers to “follow Cargill by example.” The company not only drove change within its own operations and with its customers, but it has also worked as a catalyst for global change, actively collaborating with health organizations to share expertise and support policy development in markets where iTFA regulations are still emerging.
# # #
*Industrially produced trans-fatty acids (iTFAs) are created during the partial hydrogenation of vegetable oils but can also be formed by high thermal treatment during edible oil refining. At high levels of consumption, they have been linked to increased risk of coronary heart disease and mortality, prompting the World Health Organization (WHO) to recommend eliminating iTFAs from global food supplies.
About Cargill
Cargill is committed to providing food, ingredients, agricultural solutions, and industrial products to nourish the world in a safe, responsible, and sustainable way. Sitting at the heart of the supply chain, we partner with farmers and customers to source, make and deliver products that are vital for living.
Our approximately 160,000 employees innovate with purpose, providing customers with life’s essentials so businesses can grow, communities prosper, and consumers live well. With 160 years of experience as a family company, we look ahead while remaining true to our values. We put people first. We reach higher. We do the right thing—today and for generations to come. For more information, visit Cargill.com and our News Center.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250528074187/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer Stratence Partners30.5.2025 16:07:00 CEST | Pressemeddelelse
Andersen Consulting udvider sin platform med en samarbejdsaftale med Stratence Partners, der er et konsulentfirma med base i Storbritannien, som hjælper globale virksomheder med at øge markedsandele og forbedre rentabiliteten gennem deres ekspertise inden for prisfastsættelse, strategisk optimering, kommerciel effektivitet og digital transformation. Stratence Partners har en resultatorienteret tilgang og er forpligtet på bæredygtig forandring, hvorved de hjælper deres kunder gennem en unik kombination af konsulentbistand, midlertidige ledelsesindsater og oplæringskurser samt deres egne metoder og løsninger inden for datastyring, datavidenskab (AI), værktøjer og systemer. "Samarbejdet med Andersen Consulting er et spændende skridt for vores firma," sagde Fernando Ventureira, administrerende direktør for Stratence Partners. "I vores arbejde med hos ledere over hele verden har vi erfaret, at deres behov rækker ud over strategisk prisfastsættelse og driftsoptimering. Vores kunder værdsætte
You Up? Grindr’s “Right Now” Goes Global30.5.2025 15:00:00 CEST | Press release
More places, more people – Grindr’s real-time hookup feature makes connecting faster than ever Grindr, the Global Gayborhood in Your Pocket™ with more than 14.6M average monthly active users, today announced the global launch of Right Now, their newest intent-based feature designed to instantly connect people looking for immediate encounters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530651954/en/ Grindr's Right Now feature. Right Now is a real-time feed—separate from the app’s main grid that displays profiles—where Grindr users can post text and share photos displayed for one hour, letting other like-minded users know exactly what they’re looking for. “Right Now empowers our users to find exactly what they want, when they want it – without the guesswork,” said AJ Balance, Chief Product Officer at Grindr. “We built this intention-based feature based on feedback from our community so they can connect with like-minded
CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 203030.5.2025 14:00:00 CEST | Press release
Only approximately 2 out of 10 people in the US and 3 out of 10 people in Europe with certain rare, advanced blood cancers receive access to CAR T-cell therapy1,2,3New roadmap report aims to inspire collective action of stakeholder groups and invites additional CAR T-cell therapy leaders to join the coalition Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative fin
Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA30.5.2025 11:17:00 CEST | Press release
In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/ Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & KISS, jointly inaugurate the Achyuta Samanta India Initiative of CUNY CREST Institute (ASIICCI) with a ribbon-cutting ceremony in New York. Named after Dr. Achyuta Samanta, a noted Indian educationist and social worker, the initiative focuses on academic research in Indian social and educational sectors, with a particular lens on Odisha. This marks one of the rare instances of a living Indian being honoured with such a naming in an American public university system. Dr. Samanta, who hails from Odisha
FDA Grants De Novo Clearance for Reflow Medical's Spur® Peripheral Retrievable Stent System30.5.2025 06:08:00 CEST | Press release
Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the company’s Spur Peripheral Retrievable Stent System, a unique clinical solution for the treatment of de novo or restenotic lesions following predilatation in patients with infrapopliteal arterial disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529610368/en/ The first and only retrievable stent system that features a self-expanding stent with an integrated dilatation balloon catheter on an over-the-wire system. It is designed for controlled lesion penetration and treatment through a series of radially expandable spikes. Known as Retrievable Scaffold Therapy (RST), the spikes on the Spur Stent penetrate the lesion to increase the acute luminal diameter and modify the lesion morphology to change vessel complia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom